{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:29:22Z","timestamp":1789576162529,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-75937-6","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T01:39:59Z","timestamp":1731375599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Hematological changes in women with cervical cancer before and after cancer treatment: retrospective cohort study"],"prefix":"10.1038","volume":"14","author":[{"given":"Dereje Mengesha","family":"Berta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bisrat Birke","family":"Teketelew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elias","family":"Chane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biruk","family":"Bayleyegn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mebratu","family":"Tamir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negesse","family":"Cherie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masiresha","family":"Seyoum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amare","family":"Mekuanint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melak","family":"Aynalem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"75937_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.coviro.2021.09.012","volume":"51","author":"S Regauer","year":"2021","unstructured":"Regauer, S. & Reich, O. The origin of human papillomavirus (HPV)\u2014induced cervical squamous cancer. Curr. Opin. Virol. 51, 111\u2013118 (2021).","journal-title":"Curr. Opin. Virol."},{"key":"75937_CR2","first-page":"e1772020","volume":"56","author":"DFB Ara\u00fajo","year":"2020","unstructured":"Ara\u00fajo, D. F. B., Cavalcanti, I. D., Larrazabal-Hadj-Idris, B. R. & Peres, A. L. Hematological and biochemical toxicity analysis of chemotherapy in women diagnosed with cervical cancer. Jornal Brasileiro de Patologia e Med. Laboratorial. 56, e1772020 (2020).","journal-title":"Jornal Brasileiro De Patologia E Med. Laboratorial"},{"key":"75937_CR3","doi-asserted-by":"crossref","unstructured":"Hui, B. et al. Association between bone marrow dosimetric parameters and acute hematologic toxicity in cervical cancer patients undergoing concurrent chemoradiotherapy: comparison of three-dimensional conformal radiotherapy and intensity-modulated radiation therapy.\u00a0Int. J. Gynecol. Cancer.\u00a024(9),\u00a01648\u20131652\u00a0(2014).","DOI":"10.1097\/IGC.0000000000000292"},{"key":"75937_CR4","doi-asserted-by":"crossref","unstructured":"Kumar, T. et al. Correlation between pelvic bone marrow radiation dose and acute hematological toxicity in cervical cancer patients treated with concurrent chemoradiation. Cancer Manag. Res.\u00a011, 6285\u20136297 (2019).","DOI":"10.2147\/CMAR.S195989"},{"key":"75937_CR5","doi-asserted-by":"crossref","unstructured":"Kantelhardt, E. J. et al. Cervical cancer in Ethiopia: survival of 1,059 patients who received oncologic therapy. Oncologist. 19 (7), 727\u2013734 (2014).","DOI":"10.1634\/theoncologist.2013-0326"},{"key":"75937_CR6","unstructured":"Wondimneh, B. et al. Comparison of hematological and biochemical profile changes in pre-and post-chemotherapy treatment of cancer patients attended at Ayder comprehensive specialized hospital, Mekelle, Northern Ethiopia 2019: a retrospective cohort study. Cancer Manage. Res.\u00a0625\u2013632. (2021)."},{"key":"75937_CR7","unstructured":"Abushofa, F. A., Azab, A. E. & Al Ghawi, H. M. Haematological parameter alterations among cervical cancer patients and the relationship between blood groups and cervical cancer disease. Himal. J. Appl. Med. Sci. Res. 3(2). (2022)."},{"key":"75937_CR8","doi-asserted-by":"crossref","unstructured":"Eifel, P. J. (ed) Editor Chemoradiotherapy in the Treatment of Cervical cancer. Seminars in Radiation Oncology (Elsevier, 2006).","DOI":"10.1016\/j.semradonc.2006.02.007"},{"key":"75937_CR9","doi-asserted-by":"crossref","unstructured":"Baruah, C., Paul, T., Sarma, B., Deka, K. J. & Patowory, P. P. Hematological toxicity in Carcinoma Cervix patients undergoing concurrent Chemo Radiation Therapy or Radiation Therapy alone in a Tertiary Hospital of North East India: a prospective study. Asian Pac. J. Cancer Care. 7 (4), 651\u2013655 (2022).","DOI":"10.31557\/apjcc.2022.7.4.651-655"},{"key":"75937_CR10","unstructured":"Kumar, A. et al. Correlation of hematological parameters with clinical outcomes in cervical Cancer patients treated with Radical Radio (chemo) therapy: a retrospective study. Int. J. Radiation Oncology* Biology* Phys. (2023)."},{"key":"75937_CR11","doi-asserted-by":"crossref","unstructured":"Lim, S., Lee, C-M., Park, J-M., Jung, S-Y. & Lee, K-B. An association between preoperative anemia and poor prognostic factors and decreased survival in early stage cervical cancer patients. Obstet. Gynecol. Sci. 57 (6), 471\u2013477 (2014).","DOI":"10.5468\/ogs.2014.57.6.471"},{"key":"75937_CR12","doi-asserted-by":"crossref","unstructured":"Mabuchi, S. et al. Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer. Int. J. Gynecologic Cancer ;22(9). (2012).","DOI":"10.1097\/IGC.0b013e31826ea0eb"},{"key":"75937_CR13","doi-asserted-by":"crossref","unstructured":"Wassie, M., Aemro, A. & Fentie, B. Prevalence and associated factors of baseline anemia among cervical cancer patients in Tikur Anbesa Specialized Hospital, Ethiopia. BMC Women\u2019s Health. 21 (1), 1\u20138 (2021).","DOI":"10.1186\/s12905-021-01185-9"},{"key":"75937_CR14","doi-asserted-by":"crossref","unstructured":"Yanazume, S. et al. Tumor bleeding requiring intervention and the correlation with anemia in uterine cervical cancer for definitive radiotherapy. Jpn J. Clin. Oncol. 48 (10), 892\u2013899 (2018).","DOI":"10.1093\/jjco\/hyy113"},{"key":"75937_CR15","doi-asserted-by":"crossref","unstructured":"Candelaria, M., Cetina, L. & Due\u00f1as-Gonz\u00e1lez, A. Anemia in cervical cancer patients. Med. Oncol. 22 (2), 161\u2013168 (2005).","DOI":"10.1385\/MO:22:2:161"},{"issue":"46","key":"75937_CR16","doi-asserted-by":"publisher","first-page":"74886","DOI":"10.18632\/oncotarget.12440","volume":"7","author":"A Escande","year":"2016","unstructured":"Escande, A. et al. Neutrophilia in locally advanced cervical cancer: a novel biomarker for image-guided adaptive brachytherapy? Oncotarget. 7 (46), 74886 (2016).","journal-title":"Oncotarget"},{"key":"75937_CR17","doi-asserted-by":"crossref","unstructured":"Madeddu, C. et al. Pathogenic and prognostic roles of paraneoplastic leukocytosis in Cervical Cancer: can genomic-based targeted therapies have a role? A literature review and an emblematic case report. Diagnostics. 12 (8), 1910 (2022).","DOI":"10.3390\/diagnostics12081910"},{"issue":"6","key":"75937_CR18","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.rpor.2018.09.002","volume":"23","author":"GOR Porras","year":"2018","unstructured":"Porras, G. O. R., Nogueda, J. C. & Chac\u00f3n, A. P. Chemotherapy and molecular therapy in cervical cancer. Rep. Practical Oncol. Radiotherapy. 23 (6), 533\u2013539 (2018).","journal-title":"Rep. Practical Oncol. Radiotherapy"},{"key":"75937_CR19","doi-asserted-by":"crossref","unstructured":"Ma, R. et al. Radiotherapy-induced haematological and intestinal toxicity in cervical cancer. (2021), unpublished.","DOI":"10.21203\/rs.3.rs-265849\/v1"},{"issue":"1","key":"75937_CR20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40661-016-0036-3","volume":"4","author":"A Degu","year":"2017","unstructured":"Degu, A., Njogu, P., Weru, I. & Karimi, P. Assessment of drug therapy problems among patients with cervical cancer at Kenyatta National Hospital, Kenya. Gynecologic Oncol. Res. Pract. 4 (1), 1\u201315 (2017).","journal-title":"Gynecologic Oncol. Res. Pract."},{"key":"75937_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13014-020-01606-3","volume":"15","author":"J Huang","year":"2020","unstructured":"Huang, J., Gu, F., Ji, T., Zhao, J. & Li, G. Pelvic bone marrow sparing intensity modulated radiotherapy reduces the incidence of the hematologic toxicity of patients with cervical cancer receiving concurrent chemoradiotherapy: a single-center prospective randomized controlled trial. Radiat. Oncol. 15, 1\u20139 (2020).","journal-title":"Radiat. Oncol."},{"key":"75937_CR22","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.ctro.2017.05.001","volume":"4","author":"TA Koulis","year":"2017","unstructured":"Koulis, T. A. et al. Anemia, leukocytosis and thrombocytosis as prognostic factors in patients with cervical cancer treated with radical chemoradiotherapy: a retrospective cohort study. Clin. Translational Radiation Oncol. 4, 51\u201356 (2017).","journal-title":"Clin. Translational Radiation Oncol."},{"issue":"5","key":"75937_CR23","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/01443615.2019.1586852","volume":"39","author":"BA Yildirim","year":"2019","unstructured":"Yildirim, B. A., Guler, O. C., Kose, F. & Onal, C. The prognostic value of haematologic parameter changes during treatment in cervical cancer patients treated with definitive chemoradiotherapy. J. Obstet. Gynaecol. 39 (5), 695\u2013701 (2019).","journal-title":"J. Obstet. Gynaecol."},{"issue":"15","key":"75937_CR24","doi-asserted-by":"publisher","first-page":"24327","DOI":"10.18632\/oncotarget.15358","volume":"8","author":"J Cheng","year":"2017","unstructured":"Cheng, J. et al. The association of pretreatment thrombocytosis with prognosis and clinicopathological significance in cervical cancer: a systematic review and meta-analysis. Oncotarget. 8 (15), 24327 (2017).","journal-title":"Oncotarget"},{"issue":"33","key":"75937_CR25","doi-asserted-by":"publisher","first-page":"55394","DOI":"10.18632\/oncotarget.19560","volume":"8","author":"K Kozasa","year":"2017","unstructured":"Kozasa, K. et al. Comparison of clinical utilities of the platelet count and platelet-lymphocyte ratio for predicting survival in patients with cervical cancer: a single institutional study and literature review. Oncotarget. 8 (33), 55394 (2017).","journal-title":"Oncotarget"},{"issue":"2","key":"75937_CR26","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/0973-1482.189234","volume":"13","author":"D Sharma","year":"2017","unstructured":"Sharma, D. & Singh, G. Thrombocytosis in gynecological cancers. J. Cancer Res. Ther. 13 (2), 193 (2017).","journal-title":"J. Cancer Res. Ther."},{"key":"75937_CR27","doi-asserted-by":"crossref","unstructured":"Sai Lalitha, B., Malini, M. & Botlagunta, M. (eds)\u00a0Effect of chemoradiation on haematological parameters in cervical cancer. Proceedings of the 2nd International Conference on Computational and Bio Engineering: CBE 2020, (Springer, 2021).","DOI":"10.1007\/978-981-16-1941-0_59"},{"issue":"22","key":"75937_CR28","doi-asserted-by":"publisher","first-page":"8432","DOI":"10.1002\/cam4.3465","volume":"9","author":"C Gennigens","year":"2020","unstructured":"Gennigens, C. et al. Correlation between hematological parameters and outcome in patients with locally advanced cervical cancer treated by concomitant chemoradiotherapy. Cancer Med. 9 (22), 8432\u20138443 (2020).","journal-title":"Cancer Med."},{"issue":"1","key":"75937_CR29","first-page":"115","volume":"65","author":"JD Boice","year":"1980","unstructured":"Boice, J. D. & Hutchison, G. B. Leukemia in women following radiotherapy for cervical cancer: ten-year follow-up of an international study. J. Natl Cancer Inst. 65 (1), 115\u2013129 (1980).","journal-title":"J. Natl Cancer Inst."},{"issue":"9376","key":"75937_CR30","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1016\/S0140-6736(03)13778-6","volume":"361","author":"SE Waggoner","year":"2003","unstructured":"Waggoner, S. E. Cervical cancer. Lancet. 361 (9376), 2217\u20132225 (2003).","journal-title":"Lancet"},{"issue":"10","key":"75937_CR31","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.amsu.2020.07.008","volume":"57","author":"SS Ahmed","year":"2020","unstructured":"Ahmed, S. S. & Mohammed, A. A. Effects of thyroid dysfunction on hematological parameters: Case controlled study. Annals Med. Surg. 57 (10), 52\u201355 (2020).","journal-title":"Annals Med. Surg."},{"issue":"7","key":"75937_CR32","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/tmi.13071","volume":"23","author":"B Enawgaw","year":"2018","unstructured":"Enawgaw, B. et al. Haematological and immunological reference intervals for adult population in the state of Amhara, Ethiopia. Tropical Med. Int. Health. 23 (7), 765\u2013773 (2018).","journal-title":"Tropical Med. Int. Health"},{"issue":"3","key":"75937_CR33","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.3892\/ol.2020.11754","volume":"20","author":"R Hull","year":"2020","unstructured":"Hull, R. et al. Cervical cancer in low and middle\u2013income countries. Oncol. Lett. 20 (3), 2058\u20132074 (2020).","journal-title":"Oncol. Lett."},{"issue":"3","key":"75937_CR34","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.ijrobp.2009.11.010","volume":"79","author":"BS Rose","year":"2011","unstructured":"Rose, B. S. et al. Normal tissue complication probability modeling of acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy. Int. J. Radiation Oncology* Biology* Phys. 79 (3), 800\u2013807 (2011).","journal-title":"Int. J. Radiation Oncology* Biology* Phys."},{"issue":"1","key":"75937_CR35","doi-asserted-by":"publisher","first-page":"451","DOI":"10.21873\/anticanres.13973","volume":"40","author":"HJ Lee","year":"2020","unstructured":"Lee, H. J. et al. Prognostic value of hematological parameters in locally advanced cervical cancer patients treated with concurrent chemoradiotherapy. Anticancer Res. 40 (1), 451\u2013458 (2020).","journal-title":"Anticancer Res."},{"issue":"6","key":"75937_CR36","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1080\/02841860600833160","volume":"45","author":"K Serkies","year":"2006","unstructured":"Serkies, K., Badzio, A. & Jassem, J. Clinical relevance of hemoglobin level in cervical cancer patients administered definitive radiotherapy. Acta Oncol. 45 (6), 695\u2013701 (2006).","journal-title":"Acta Oncol."},{"key":"75937_CR37","doi-asserted-by":"crossref","unstructured":"Barkati, M. et al. Hemoglobin level in cervical cancer: a surrogate for an infiltrative phenotype. Int. J. Gynecologic Cancer 23(4). (2013).","DOI":"10.1097\/IGC.0b013e31828a0623"},{"issue":"1","key":"75937_CR38","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.ijrobp.2014.09.023","volume":"91","author":"AJ Bishop","year":"2015","unstructured":"Bishop, A. J., Allen, P. K., Klopp, A. H., Meyer, L. A. & Eifel, P. J. Relationship between low hemoglobin levels and outcomes after treatment with radiation or chemoradiation in patients with cervical cancer: has the impact of anemia been overstated? Int. J. Radiation Oncology* Biology* Phys. 91 (1), 196\u2013205 (2015).","journal-title":"Int. J. Radiation Oncology* Biology* Phys."},{"key":"75937_CR39","doi-asserted-by":"publisher","first-page":"153303382211181","DOI":"10.1177\/15330338221118188","volume":"21","author":"E Meixner","year":"2022","unstructured":"Meixner, E. et al. Age-dependent hematologic toxicity profiles and prognostic serologic markers in postoperative Radiochemotherapy treatment for uterine cervical Cancer. Technol. Cancer Res. Treat. 21, 15330338221118188 (2022).","journal-title":"Technol. Cancer Res. Treat."},{"key":"75937_CR40","unstructured":"Ramatillah, D. L., Gillani, S. W. & Suardi, M. Evaluation of patient treatment response in oncology ward of teaching hospital. Int. J. Pharm. Life Sci(IJPLS). 3 (11), 2082\u20132089 (2012)."},{"key":"75937_CR41","doi-asserted-by":"crossref","unstructured":"Mell, L. K. et al. Dosimetric predictors of acute hematologic toxicity in cervical cancer patients treated with concurrent cisplatin and intensity-modulated pelvic radiotherapy. Int. J. Radiation Oncology* Biology* Phys. 66 (5), 1356\u20131365 (2006).","DOI":"10.1016\/j.ijrobp.2006.03.018"},{"key":"75937_CR42","doi-asserted-by":"crossref","unstructured":"Li, J., Yang, X., Ma, J., Gong, F. & Chen, Q. Relationship of red blood cell distribution width with cancer mortality in hospital. BioMed Res. Int. 2018. (2018).","DOI":"10.1155\/2018\/8914617"},{"key":"75937_CR43","doi-asserted-by":"crossref","unstructured":"Noh, J. J. et al. The prognostic model of pre-treatment complete blood count (CBC) for recurrence in early cervical cancer. J. Clin. Med. 9 (9), 2960 (2020).","DOI":"10.3390\/jcm9092960"},{"key":"75937_CR44","first-page":"211","volume":"3","author":"R Shrivastava","year":"2009","unstructured":"Shrivastava, R., Sharma, N., Rathore, S. & Rathore, R. Biochemical and hematological changes during the course of radiotherapy in cervix cancer patients in Gwalior region of India. Pharmacol. Online. 3, 211\u2013214 (2009).","journal-title":"Pharmacol. Online"},{"issue":"3","key":"75937_CR45","doi-asserted-by":"publisher","first-page":"155932581987419","DOI":"10.1177\/1559325819874199","volume":"17","author":"J Wang","year":"2019","unstructured":"Wang, J. et al. Prognostic values of platelet-associated indicators in resectable cervical cancer. Dose-Response. 17 (3), 1559325819874199 (2019).","journal-title":"Dose-Response"},{"key":"75937_CR46","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1385\/MO:22:2:161","volume":"22","author":"M Candelaria","year":"2005","unstructured":"Candelaria, M., Cetina, L. & Due\u00f1as-Gonz\u00e1lez, A. Anemia in cervical cancer patients: implications for iron supplementation therapy. Med. Oncol. 22, 161\u2013168 (2005).","journal-title":"Med. Oncol."},{"issue":"2","key":"75937_CR47","doi-asserted-by":"publisher","first-page":"176","DOI":"10.5468\/ogs.21308","volume":"65","author":"F Shi","year":"2022","unstructured":"Shi, F. et al. Impact of hematologic toxicities during concurrent chemoradiation for cervical cancer. Obstet. Gynecol. Sci. 65 (2), 176\u2013187 (2022).","journal-title":"Obstet. Gynecol. Sci."},{"issue":"2","key":"75937_CR48","first-page":"127","volume":"22","author":"P Yuenyao","year":"2007","unstructured":"Yuenyao, P. et al. Hematologic toxicities of cisplatin concurrent chemoradiation in cervical cancer at Ubonrajchathani Cancer Center. Srinagarind Med. J. 22 (2), 127\u2013132 (2007).","journal-title":"Srinagarind Med. J."},{"key":"75937_CR49","doi-asserted-by":"crossref","unstructured":"Obermair, A. et al. Anemia before and during concurrent chemoradiotherapy in patients with cervical carcinoma: effect on progression-free survival. Int. J. Gynecologic Cancer 13(5). (2003).","DOI":"10.1136\/ijgc-00009577-200309000-00010"},{"key":"75937_CR50","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.critrevonc.2016.06.001","volume":"105","author":"S Shahid","year":"2016","unstructured":"Shahid, S. Review of hematological indices of cancer patients receiving combined chemotherapy & radiotherapy or receiving radiotherapy alone. Crit. Rev. Oncol. Hematol. 105, 145\u2013155 (2016).","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"75937_CR51","volume-title":"Basic Principles and Practice E-Book: Basic Principles and Practice","author":"LE Silberstein","year":"2017","unstructured":"Silberstein, L. E., Anastasi, J. & Hematology Basic Principles and Practice E-Book: Basic Principles and Practice (Elsevier Health Sciences, 2017)."},{"key":"75937_CR52","doi-asserted-by":"crossref","unstructured":"Tonia, T. et al. Erythropoietin or darbepoetin for patients with cancer. Cochrane Database Syst. Reviews 2012(12).","DOI":"10.1002\/14651858.CD003407.pub5"},{"key":"75937_CR53","volume-title":"Current and emerging standards of concomitant chemoradiotherapy. Seminars in oncology","year":"2008","unstructured":"Adelstein, D. J. & Rodriguez, C. P. (eds) Current and Emerging Standards of Concomitant Chemoradiotherapy. Seminars in Oncology (Elsevier, 2008)."},{"key":"75937_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12957-019-1676-7","volume":"17","author":"W Cao","year":"2019","unstructured":"Cao, W. et al. Prognostic role of pretreatment thrombocytosis on survival in patients with cervical cancer: a systematic review and meta-analysis. World J. Surg. Oncol. 17, 1\u201310 (2019).","journal-title":"World J. Surg. Oncol."},{"key":"75937_CR55","unstructured":"Kiptoo, V. K. & Prevalence Risk Factors and Interventional Strategies for Management of Thrombocytopenia among Adult Patients Treated for Cancer at (University of Nairobi, 2023)."},{"key":"75937_CR56","doi-asserted-by":"crossref","unstructured":"Gavrilescu, M. M. et al. Clinical value of hematological biomarkers in uterine cervical cancer. Chirurgia. 111, 493\u2013499 (2016).","DOI":"10.21614\/chirurgia.111.6.493"},{"key":"75937_CR57","doi-asserted-by":"crossref","unstructured":"Onal, C., Guler, O. C. & Yildirim, B. A. Prognostic use of pretreatment hematologic parameters in patients receiving definitive chemoradiotherapy for cervical cancer. Int. J. Gynecologic Cancer 26(6). (2016).","DOI":"10.1097\/IGC.0000000000000741"},{"key":"75937_CR58","unstructured":"Tadesse, S. Preventive mechanisms and treatment of cervical cancer in Ethiopia. Gynecol. Obstet. (Sunnyvale). 5 (101), 2161\u20130932 (2015)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75937-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75937-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75937-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T12:19:38Z","timestamp":1731673178000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-75937-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["75937"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-75937-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"10 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"We confirm that all the procedures were performed in accordance with the relevant guidelines and regulations. Ethical approval was obtained from the Ethical Review Committee of the School of Biomedical and Laboratory Sciences, College of Medicine and Health Science, the University of Gondar (SBLS\/194\/2015). The objective and purpose of the study were explained to the medical director and cancer treatment director, and permission was obtained to collect the data. Since the study was retrospective, informed consent was waived by ethical review committee of the School of Biomedical and Laboratory Sciences, College of Medicine and Health Sciences University of Gondar. No personal identifiers were used for confidentiality. In addition, to keep patient information confidential, a password was used to limit access to the data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate and ethical approval"}},{"value":"Not applicable. This manuscript does not contain any individual data.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"27630"}}